100+
installs · ≈124
—
0 ratings
2024-07-02
first release
2026-02-20
last update
Description
Study for patients with KRAS G12C-Mutant, Metastatic Non-Small Cell Lung Cancer
A Multicenter, Randomized, Phase 3 Study Comparing LY3537982 and Pembrolizumab to Placebo and Pembrolizumab as First-Line Treatment in Patients with KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression (TPS ≥ 50%). This app is specifically intended for participants in the J3M-MC-JZQB study only.
What's new
Bug fixes and performance improvements
Details
| Version | 5.4.1200.2-prod |
|---|---|
| Minimum Android version | 8.0 |
| Reviews | 0 |
| Available in | American Samoa, Austria, Australia, Belgium, Bulgaria, St. Barthélemy, Brazil, Canada, Switzerland, Czechia, Germany, Denmark and 38 more |
| Developer contacts | on the Business plan |
| Collected | 2026-11-15 |
This data in the API
The full record in JSON costs 1 token.
curl -H "X-API-Key: YOUR_KEY" \ "https://apkapi.com/api/v1/app?id=com.medable.lilly.jzqb"
